ML
Meir Lahav(1936)
ChemistryMeir Lahav is a recipient of the Wolf Prize in Chemistry (2021) from Israel. Their primary field is Chemistry. They were educated at Harvard University and Hebrew University of Jerusalem. They have been affiliated with Weizmann Institute of Science.
Israel
1
Major Awards
7
Publications
213
Citations
5
h-index
N/A
i10-index
30.4
Avg Citations/Paper
Awards & Recognition
Recent Publications
View all worksChronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles Educate Endothelial Cells to Become IL-6-Producing, CLL-Supportive Cells
Biomedicines2024
4citations
Open AccessIs serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study
Cancer Medicine2023
7citations
Open AccessDifferential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo
British Journal of Cancer2012
17citations
Open AccessImatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines
British Journal of Cancer2005
85citations
Open AccessExternal Profiles
Co-winners
Shared the same award in the same year
Education
Harvard University
Hebrew University of Jerusalem
Weizmann Institute of Science(Doctor of Philosophy)
Doctoral Advisors
Gerhard SchmidtLia Addadi
Related Laureates
Other winners of the same award(s)
SD
Samuel Danishefsky
Wolf Prize in Chemistry (2000)
OY
Omar Yaghi
Nobel Prize in Chemistry (2025)
HS
Helmut Schwarz
Wolf Prize in Chemistry (2025)
RL
Robert Langer
Kavli Prize in Nanoscience (2024)
CR
Carolyn R. Bertozzi
Priestley Medal (2023)
BL
Bonnie L. Bassler
Gairdner International Award (2023)
JW
Jeffery W. Kelly
Wolf Prize in Chemistry (2023)
CH
Chuan He
Wolf Prize in Chemistry (2023)
Data Sources
Profile data aggregated from Semantic Scholar, Wikidata, ORCID, and curated award records. Citation metrics may vary between sources.